MENTOR, Ohio — Mentor manufacturing and technology company Steris Corp. has asked the Food and Drug Administration to approve a new chemical sterilization system for sale.
Once approved, the yet unnamed system eventually will replace System 1, the first medical instrument sterilizer launched by Steris in 1988.
The premarket approval filing by Steris is aimed at putting to rest issues raised in a warning letter from the FDA in mid-May, Steris said in a written statement. The FDA said that Steris probably should have notified the federal regulator of substantial changes made to System 1 over the two decades it has been sold.
“We’re in the process now of reaching out to all our U.S. customers to explain what we announced today,” he said.
Innovation, influence and business in America's medical cities.
Comments
Post a comment
[...] STERIS filed a 510(k) for a next-generation System 1 in January. “We continue to work diligently with the agency to answer questions regarding [...]
Comment by STERIS Corp. profits flat in first fiscal quarter; revenues fall 9 percent : MedCity News — July 30, 2009 @ 3:10 pm
[...] company said it had submitted for FDA review an updated version of the device. Once the new version is cleared, Steris would work with customers [...]
Comment by FDA: Steris device could cause ’serious injuries’ to patients : MedCity News — December 4, 2009 @ 11:51 am
[...] in January the company asked the FDA to approve a new chemical sterilization system for sale, partly to put to rest its ongoing disagreement with the regulator. The new system eventually [...]
Comment by STERIS shares rebound slightly from 12 percent hit following FDA safety alert : MedCity News — December 7, 2009 @ 5:38 pm
[...] of making a new application to market System 1, STERIS applied to the FDA on Jan. 5 to sell a next-generation chemical sterilization system – essentially an updated and improved System 1 — largely to put to rest its ongoing [...]
Comment by STERIS turns corner in disagreement with FDA on System 1 sterilizer : MedCity News — December 11, 2009 @ 8:20 pm
[...] year ago, STERIS asked the FDA to approve a kind of System 1.5. “While we are focused to assist customers as they look to transition from System 1, we [...]
Comment by STERIS reports higher quarterly profits, revenue but also uncertainty about future earnings : MedCity News — February 3, 2010 @ 5:27 pm
Post a Comment